Point of Care Molecular Diagnostics Market to Amass Huge Share: Key Players: Sysmex Corporation, bioMérieux, Bio-Rad Laboratories, Danaher Corporation
The Point of Care Molecular Diagnostics Market is set to exceed USD 2.5 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increasing awareness regarding pre-disease diagnosis along with growing incidence of infectious diseases will drive point of care molecular diagnostics market growth. Growing R&D focused on reducing time required for molecular tests will further propel industry growth. However, long product development time and complex regulatory process will hamper the business acceleration.
View full press release